Acorai MLG Study

  • Research type

    Research Study

  • Full title

    “A Multi-Site Observational Clinical Investigation to Collect Non-invasive Sensor Data During a Right Heart Catheterization and Train Machine Learning Models to Estimate Intracardiac Hemodynamic Parameters”

  • IRAS ID

    328221

  • Contact name

    Helmine Verhoeven

  • Contact email

    helmine.verhoeven@acorai.com

  • Sponsor organisation

    Acorai AB

  • Clinicaltrials.gov Identifier

    NCT05835024

  • Duration of Study in the UK

    0 years, 6 months, 2 days

  • Research summary

    Acorai is developing the Acorai Heart Monitor, a handheld electronic device for monitoring pressures inside the heart in a non-invasive way, simply by placing the device on the chest of a patient. Currently these intracardiac pressures are measured in an invasive way, during a catheterisation. There is a clinical need for a non -invasive, easy to use, tool to monitor patients that (may) suffer from heart failure. For the development of the monitor, Acorai is conducting a data collection study. Data from patients undergoing a right heart catheterisation is collected and used to built the software needed for the final device, the heart monitor. People undergoing a right heart cath will be invited to participate. Hospital from the UK, US and Europe will be involved in this study. A total of 1200 patients will be participating.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    23/PR/0556

  • Date of REC Opinion

    26 Jul 2023

  • REC opinion

    Further Information Favourable Opinion